Restart Anticoagulation in Patients With Spontaneous Intracerebral Hemorrhage and Mechanical Heart Valves

Cerebral Hemorrhage Clinical Trial

Official title:

Restart Anticoagulation in Patients With Spontaneous Intracerebral Hemorrhage and Mechanical Heart Valves

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04450446
• Other study ID #: 2020-315
• Status: Recruiting
• Start date: January 1, 2015
• Est. completion date: August 31, 2020

Study information

• Verified date: June 2020
• Source: Second Affiliated Hospital, School of Medicine, Zhejiang University
• Contact: rubin luo, MD
• Phone: +86057187783759
• Email: keyanlunli_zheer[@]163.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators retrospectively reviewed the electronic medical records of the patients with spontaneous cerebral hemorrhage and mechanical valves from 2015 to 2020 in the second affiliated hospital of Zhejiang university medical college. Medical documents and patient data were reviewed, including patient age, gender, type of mechanical heart valve, replacement time, replacement site, underlying disease, anticoagulant drugs at admission, type of cerebral hemorrhage, treatment mode, time without anticoagulant, length of stay, mortality, etc

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: August 31, 2020
• Est. primary completion date: August 31, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients with spontaneous cerebral hemorrhage and mechanical valves

Exclusion Criteria:

• age<18y

• pregnant patients

• death in 24 hours without anticoagulant

Related Conditions & MeSH terms

• Cerebral Hemorrhage
• Hemorrhage

Intervention

Drug:
• Low molecular weight heparin
Anticoagulation therapy

Locations

Country	Name	City	State
China	Second Affiliated Hospital, School of Medicine, Zhejiang University, China	Hangzhou	Zhejiang
China	Second Affiliated Hospital,School of Medicine, Zhejiang University	Hangzhou	Zhejiang

Sponsors (1)

Lead Sponsor	Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	survival and death patients after follow-up investigation for 60 months	the patients with spontaneous cerebral hemorrhage and mechanical valves in the second affiliated hospital of Zhejiang university medical college.	2015-2020